Cite
Bivalirudin versus Heparin Monotherapy in Myocardial Infarction
MLA
Erlinge, D., et al. Bivalirudin versus Heparin Monotherapy in Myocardial Infarction. 2017. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsoai&AN=edsoai.on1234537304&authtype=sso&custid=ns315887.
APA
Erlinge, D., Omerovic, E., Frobert, O., Linder, R., Danielewicz, M., Hamid, M., Swahn, E., Henareh, L., Wagner, H., Hardhammar, P., Sjogren, I., Stewart, J., Grimfjard, P., Jensen, J., Aasa, M., Robertsson, L., Lindroos, P., Haupt, J., Wikstrom, H., … James, S. (2017). Bivalirudin versus Heparin Monotherapy in Myocardial Infarction.
Chicago
Erlinge, D., E. Omerovic, O. Frobert, R. Linder, M. Danielewicz, M. Hamid, Eva Swahn, et al. 2017. “Bivalirudin versus Heparin Monotherapy in Myocardial Infarction.” http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsoai&AN=edsoai.on1234537304&authtype=sso&custid=ns315887.